Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it

Stanley Nattel*, Philip T. Sager, Jorg Huser, Jordi Heijman, Dobromir Dobrev

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)1616-1631
Number of pages16
JournalCardiovascular Research
Volume117
Issue number7
DOIs
Publication statusPublished - 15 Jun 2021

Keywords

  • ANTIARRHYTHMIC AGENT
  • Antiarrhythmic drugs
  • Atrial fibrillation
  • CATHETER ABLATION
  • EUROPEAN-SOCIETY
  • HEART-FAILURE
  • ION CHANNELS
  • MECHANISMS
  • Mechanisms
  • POTASSIUM CURRENT
  • Personalized therapy
  • RHYTHM CONTROL
  • Remodelling
  • SYMPTOM BURDEN
  • UPSTREAM THERAPIES
  • MANAGEMENT

Cite this